0001387131-19-005129.txt : 20190716
0001387131-19-005129.hdr.sgml : 20190716
20190716203339
ACCESSION NUMBER: 0001387131-19-005129
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190712
FILED AS OF DATE: 20190716
DATE AS OF CHANGE: 20190716
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDSTEIN DOV A MD
CENTRAL INDEX KEY: 0001120478
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35963
FILM NUMBER: 19958105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuBase Therapeutics, Inc.
CENTRAL INDEX KEY: 0001173281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465622433
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 700 TECHNOLOGY DRIVE
CITY: PITTSBURGH
STATE: PA
ZIP: 15219
BUSINESS PHONE: 6464501790
MAIL ADDRESS:
STREET 1: 700 TECHNOLOGY DRIVE
CITY: PITTSBURGH
STATE: PA
ZIP: 15219
FORMER COMPANY:
FORMER CONFORMED NAME: Ohr Pharmaceutical Inc
DATE OF NAME CHANGE: 20090819
FORMER COMPANY:
FORMER CONFORMED NAME: BBM HOLDINGS, INC.
DATE OF NAME CHANGE: 20070402
FORMER COMPANY:
FORMER CONFORMED NAME: PRIME RESOURCE INC
DATE OF NAME CHANGE: 20020513
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2019-07-12
0
0001173281
NeuBase Therapeutics, Inc.
NBSE
0001120478
GOLDSTEIN DOV A MD
C/O 700 TECHNOLOGY DRIVE, THIRD FLOOR
PITTSBURGH
PA
15219
1
0
0
0
Stock option (right to buy)
5.39
2019-07-12
4
A
0
227330
0
A
2029-07-12
Common stock
227330
227330
D
1/36th of the total shares subject to the option shall vest monthly over three years.
/s/ Sam Backenroth, as attorney-in-fact for Dov A. Goldstein
2019-07-16